Featured Research

from universities, journals, and other organizations

Study points to way of improving chemotherapy response

Date:
September 8, 2011
Source:
University of Oxford
Summary:
Blocking key proteins could improve response to a common chemotherapy drug, suggests a new study which used cancer cells grown in the lab.

Paclitaxel blocks cancer growth by stopping cells separating into two new cells.
Credit: Image courtesy of University of Oxford

Blocking key proteins could improve response to a common chemotherapy drug, suggests an Oxford University-led study which used cancer cells grown in the lab.

The research offers several new targets for developing future drugs to boost the success rate of the tumour-shrinking drug paclitaxel (Taxol).

Paclitaxel is a chemotherapy drug commonly used to treat breast and ovarian cancer, but some tumours can become resistant over time and start growing again. The drug blocks the growth of cancer by interfering with microtubules -- structures that help chromosomes to separate during cell division.

The international team of researchers found that blocking certain proteins stabilised the microtubules and made ovarian cancer cells more sensitive to paclitaxel. The findings are published in the journal Cancer Research.

Lead researcher Dr Ahmed Ahmed of the University of Oxford said: 'Our work provides further evidence for the important link between the stability of microtubules, the backbone of the cell, and sensitivity to paclitaxel.

'And because the proteins we've identified share the same target as paclitaxel, it raises the prospect of developing more specific drugs that sensitise cancer cells to paclitaxel without damaging the surrounding tissues.'

Previous research by Dr Ahmed and colleagues in the Nuffield Department of Obstetrics and Gynaecology found that the loss of a protein called TGFBI -- which sends messages that stabilise the microtubules -- caused paclitaxel to fail.

So to test the theory that microtubule stability may be essential for paclitaxel response, the researchers systematically blocked other signalling proteins in ovarian cancer cells growing in the lab, to see which might alter paclitaxel response.

Dr Robert Bast of the University of Texas MD Anderson Cancer Centre, who was also involved in the work, said: 'Our study has revealed several new proteins involved in microtubule stability that could be potential targets for drugs to improve the sensitivity of cancer cells to paclitaxel, without damaging healthy cells.'

The research was funded by Cancer Research UK, the University of Oxford, the Camilla Samuel Fund, and the MD Anderson Cancer Center.

Dr Julie Sharp, senior science information manager at Cancer Research UK, said: 'Overcoming drug resistance is a key challenge for our researchers. Unravelling the genetic basis of cancer to find out what determines whether a patient will respond to treatment will help us take a more targeted approach to tackle this problem. This approach could lead to fewer side effects and provide a lifeline for patients who have stopped responding to conventional treatments.'


Story Source:

The above story is based on materials provided by University of Oxford. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. A. Ahmed, X. Wang, Z. Lu, J. Goldsmith, X.-F. Le, G. Grandjean, G. Bartholomeusz, B. Broom, R. C. Bast. Modulating Microtubule Stability Enhances the Cytotoxic Response of Cancer Cells to Paclitaxel. Cancer Research, 2011; 71 (17): 5806 DOI: 10.1158/0008-5472.CAN-11-0025

Cite This Page:

University of Oxford. "Study points to way of improving chemotherapy response." ScienceDaily. ScienceDaily, 8 September 2011. <www.sciencedaily.com/releases/2011/09/110903101656.htm>.
University of Oxford. (2011, September 8). Study points to way of improving chemotherapy response. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2011/09/110903101656.htm
University of Oxford. "Study points to way of improving chemotherapy response." ScienceDaily. www.sciencedaily.com/releases/2011/09/110903101656.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins